Mariia Ivanova, transl. 2021. Guideline Summary NGC (2016): Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes. KIDNEYS. 4.18 (Sep. 2021), 36. DOI:https://doi.org/10.22141/2307-1257.4.18.2016.84326.